Bioteque (ROCO:4107) ROE % Adjusted to Book Value: 7.65% (As of Dec. 2025)


ROCO:4107 Bioteque Corp ROCO:4107
85 GF Score
Price NT$117.00
GF Value NT$129.27
Valuation Fairly Valued
View Full Analysis

What is Bioteque ROE % Adjusted to Book Value?

Bioteque ROCO:4107 85 ROE % Adjusted to Book Value is 7.65% as of Dec. 2025. GuruFocus rates ROCO:4107 with a GF Score™ of 85/100 and a GF Value™ of NT$129.27 (Fairly Valued).

Bioteque's ROE % for the quarter that ended in Dec. 2025 was 17.67%. Bioteque's PB Ratio for the quarter that ended in Dec. 2025 was 2.31. Bioteque's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 7.65%.

Bioteque ROE % Adjusted to Book Value Related Terms

Bioteque ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Bioteque's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque ROE % Adjusted to Book Value Chart

Bioteque Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.58 6.64 6.09 6.40 6.62

Bioteque Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.41 6.20 5.53 6.74 7.65

ROCO:4107 vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Bioteque's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioteque ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bioteque's ROE % Adjusted to Book Value falls into.


ROCO:4107
85GF Score
Bioteque Corp ROCO:4107
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque ROE % Adjusted to Book Value Calculation

Bioteque's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=15.30% / 2.31
=6.62%

Bioteque's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=17.67% / 2.31
=7.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 7.65% mean?
Bioteque (ROCO:4107) has a ROE % Adjusted to Book Value of 7.65% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bioteque and its competitors.
Is Bioteque's ROE % Adjusted to Book Value too high?
Bioteque's current ROE % Adjusted to Book Value is 7.65%. Overall, Bioteque has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's ROE % Adjusted to Book Value compare to ISRG and BDX?
Bioteque's ROE % Adjusted to Book Value of 7.65% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bioteque and its competitors. Bioteque's current ROE % Adjusted to Book Value is 7.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Fairly Valued. The stock's GF Value™ is NT$129.27, compared to a current price of NT$117.00 — trading 9.5% below its estimated fair value. The current ROE % Adjusted to Book Value is 7.65%. Bioteque's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current ROE % Adjusted to Book Value is 7.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$117.00 is trading 9.5% below its estimated GF Value™ of NT$129.27. GuruFocus considers Bioteque to be Fairly Valued.

Key valuation signals for ROCO:4107:

  • ROE % Adjusted to Book Value: 7.65%
  • GF Value™: NT$129.27 vs. price of NT$117.00 (9.5% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
85GF Score

Get the complete analysis for ROCO:4107

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$117.00
Price
NT$129.27
GF Value